Parkinson’s Disease Management in Developing Countries

Parkinson’s disease is a neurodegenerative disorder that affects millions of individuals worldwide, with a substantial impact on their quality of life. While the management of Parkinson’s disease has advanced significantly in developed countries, developing nations face unique challenges in providing adequate care and support for affected individuals. This chapter discussed the management of Parkinson’s disease in developing countries, highlighting achievements, challenges, and recommendations. Achievements in managing Parkinson’s disease in developing countries include increased awareness, improved access to medications, the establishment of rehabilitation services, and the emergence of support groups. Telemedicine has also played a crucial role, offering remote consultations and support, especially during the COVID-19 pandemic. However, challenges persist, including limited access to health care, affordability of medications, stigma, and a shortage of specialized care providers. These issues are compounded by economic constraints and inadequate infrastructure. To improve Parkinson’s disease management in developing countries, several recommendations are proposed. These include raising awareness through public campaigns, enhancing healthcare professional training, expanding telemedicine services, establishing multidisciplinary care teams, and supporting patient and caregiver education. Additionally, creating national registries, addressing stigma, and exploring sustainable financing models are crucial steps forward. Moreover, community engagement and partnerships with international organizations are essential for mobilizing resources and expertise. Integrating traditional medicine, promoting cultural competence, and developing home-based rehabilitation programs can enhance care delivery. Long-term care planning, patient advocacy networks, and research collaboration are also vital components of a holistic strategy. In conclusion, addressing the unique challenges of managing Parkinson’s disease in developing countries requires a multifaceted and collaborative approach. By implementing these recommendations, these nations can work toward equitable care, improved quality of life, and reduced disparities in Parkinson’s disease management. It is imperative that governments, healthcare organizations, advocacy groups, and the international community join forces to create a more supportive and inclusive environment for individuals living with Parkinson’s disease in developing countries.